hypertonic saline mixed Dextran

also known as HSD · Hypertonic Saline Dextran

Developed for: traumatic brain injury
Investigated by: Defence Research and Development Canada · Sunnybrook Health Sciences Centre

today NCT01642524 · Ph 3

200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 3	NCT01642524	Apr 2004 → Jan 2006	traumatic brain injury	Sunnybrook Health Sciences Centre	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	hypertonic saline mixed Dextran	ClinicalTrials.gov intervention name — accepted as the source's own label NCT01642524 ↗
Known as	HSD	“adverse rate of Hypertonic Saline Dextran (HSD) infusion” NCT01642524 ↗
Known as	Hypertonic Saline Dextran	“adverse rate of Hypertonic Saline Dextran (HSD) infusion” NCT01642524 ↗
Route	Intravenous	“single dose administered intravenously” NCT01642524 ↗